✉news BusinessBusiness first seen 1 d ago, last 1 d ago, peak #29

GE HealthCare to buy Sofie Biosciences for $945 million

Original: GE HealthCare to buy Sofie Biosciences for $945 million to strengthen radiopharma business

GE HealthCare has agreed to acquire Sofie Biosciences for $945 million, a deal aimed at strengthening the company's radiopharmaceutical business. Radiopharmaceuticals, which combine radioactive compounds with targeted therapies for diagnostics and cancer treatment, are a fast-growing area of medical technology, and the acquisition signals GE HealthCare's push to expand beyond imaging equipment into this market.

Why now: The $945 million acquisition highlights the growing industry race in radiopharmaceuticals and diagnostics

GE HealthCareSofie Biosciences

Open on news →

Evidence

• GE HealthCare to buy Sofie Biosciences for $945 million to strengthen radiopharma business · Reuters

API: https://socialmediatrends-api.osmike.com/v1/trends/1113945